Detection of M-proteins via mass spectrometry: A persistent finding
Overview
This study evaluates the persistence of M-proteins in patients with monoclonal gammopathy of undetermined significance (MGUS) using mass spectrometry (Mass-Fix). Findings indicate a high rate of persistence, particularly in cases where M-protein constitutes a larger proportion of its respective isotype.
Background
Monoclonal gammopathy of undetermined significance (MGUS) is a common plasma cell disorder, especially in individuals over 50 years of age. Although often considered benign, MGUS has significant long-term implications, including the risk of progression to multiple myeloma. The introduction of mass spectrometry for M-protein detection offers enhanced sensitivity and specificity compared to traditional methods.
Data Highlights
Finding
Percentage
Overall persistence of M-proteins
97%
Persistence of low-level M-proteins (1-10%)
93%
Persistence when M-protein exceeds 10%
99.8%
Key Findings
Mass-Fix identified M-proteins that persisted for at least 6 months in 97% of cases.
Persistence was 99.8% when M-protein exceeded 10% of the total Ig of its heavy chain isotype.
Among low-level M-proteins (1-10%), persistence was observed in 93% of cases.
Clinical progression occurred across all isotype groups, except for low-level IgM M-proteins below 50%.
Immunoparesis is a recognized risk factor for MGUS progression.
Clinical Implications
The findings suggest relevance for ongoing monitoring of MGUS patients, particularly considering the percentage of M-protein in relation to its isotype.
Conclusion
The study highlights the effectiveness of mass spectrometry in detecting persistent M-proteins in MGUS.
